| Welcome to Rhophylac.Com® Important Safety Information. Rhophylac ®, Rh o (D), Immune Globulin Intravenous (Human), is indicated for suppression of rhesus (Rh) isoimmunization in: Read More |
| Rhophylac Information from Drugs.com Rhophylac (Rho(D) immune globulin) prevents an immune response to Rh positive blood in people with an Rh negative blood type. Includes Rhophylac side effects ... Read More |
| Rhophylac Official FDA information, side effects and uses. Accurate, FDA approved Rhophylac information for healthcare professionals and patients - brought to you by Drugs.com. Read More |
| CSL Behring USA| Rhophylac Get the answers to your questions about Rhophylac. ... Rhophylac ® Rho(D) Immune Globulin Intravenous (Human) Q. What is hemolytic disease of the newborn (HDN)? Read More |
| Rhophylac (Immune Globulin Intravenous (Human) solution) Drug ... Learn about the prescription medication Rhophylac (Immune Globulin Intravenous (Human) solution), drug uses, dosage, side effects, drug interactions, warnings ... Read More |
| About Rhophylac® Learn more about Rhophylac and the treatment of Rh-sensitization. Read More |
| Rhophylac: treatment for the suppression of rhesus (Rh ... Rhophylac® is indicated to raise platelet counts in Rho(D)-positive, non-splenectomized adult patients with chronic immune thrombocytopenic purpura (ITP). For the ... Read More |
| Rhophylac - U S Food and Drug Administration Home Page Rhophylac. Proper Name: Rh0(D) Immune Globulin Intravenous (Human) Tradename: Rhophylac Manufacturer: CSL Behring AG, License #1766 Indication: Routine antepartum and ... Read More |
| Rhophylac® is now indicated to raise platelet counts in Rh0(D ... Rhophylac® is now indicated to raise platelet counts in Rh0(D)-positive, non-splenectomized adult patients with chronic ITP. Read More |
| RHOPHYLAC® - CSL Limited is a global biotherapy industry leader. RHOPHYLAC ® Human Anti-D immunoglobulin, solution for injection in a pre-filled syringe RHOPHYLAC ®, manufactured by CSL Behring, will be distributed from early ... Read More |
